Objectives and Scope
The aim of the Biomedical Catalyst is to support the development of innovative healthcare products, technologies and processes. Support is available for any sector or discipline, including but not limited to:
The aim of the early stage award is to create a data package that is sufficient to support the subsequent testing of products or process in a clinical setting or other relevant environment. It can include:
Only UK organisations are eligible to participate. All projects must be led by a UK based SME.
The total funding allocated for early stage awards is £8m. Project costs of between £200k to £1.5m are expected for projects with durations of up to 2 years.
Successful applicants can receive funding:
Large organisations are not eligible for funding.
Research organisation funding is capped at 50% of total eligible project costs, which is to be shared between such organisations if more than one participates.